Product Image

Melatonin 3 mg Timed Release

Source Naturals
4.6
★ ★ ★ ★ ★
(394 ratings)
Melatonin 3 mg
Product Image
Score84
A useful timed-release option for sleep maintenance with a moderate melatonin amount. Half-tablet dosing is its main practical weakness.
How scoring works
Quantity:240 Tablet(s) • (240 servings)
Goals:
Sleep Support

Score 84

A useful timed-release option for sleep maintenance with a moderate melatonin amount. Half-tablet dosing is its main practical weakness.
How scoring works
$26.08($0.10 per serving)
iHerb
$ 26.08
Pure Formulas
$ 26.08
Vitacost
$ 26.08
Report prices

Analysis

Timed release extends melatonin delivery and may suit people who wake during the night as well as those who struggle to fall asleep. The 3 mg amount is moderate and clearly listed.

A half-tablet is required for the stated serving, which is less convenient than taking one intact unit. Splitting may also reduce dose consistency if the tablet is not scored or does not break evenly.

The long supply and release design give the product a useful practical niche. Morning grogginess or vivid dreams remain possible, particularly when extended delivery carries effects closer to waking time.

Who is it for
  • Adults who wake during the night
  • Users comfortable splitting tablets
  • People seeking both onset and maintenance support
Best for
  • Sleep maintenance
  • Circadian support with extended delivery
  • Long-term supply value

Pros

  • Timed-release design
  • Clearly disclosed 3 mg amount
  • Long supply per bottle

Cons

  • Requires a half-tablet serving
  • Split doses may be uneven
  • Timed release may increase morning carryover for some users

Warnings

  • Melatonin may cause next-day drowsiness, vivid dreams, or headache
  • Do not crush the timed-release tablet unless the label permits it
  • Avoid driving until the morning effect is known

Nutrient quality

91 Highest impact

The practical melatonin amount is well aligned with sleep support. Timed release adds a meaningful sleep-maintenance advantage.

.

Ingredient transparency

85 Highest impact

Active amounts and the basic serving format are clear without hidden blends. Full directions, source purity, and inactive ingredients remain incomplete.

.

Customer satisfaction

64 Moderate impact

The supplied aggregate satisfaction signal is favorable and has some support from its response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

93 Highest impact

The dose, format, and serving value make the product competitively positioned. Only incomplete purity or excipient detail limits the comparison.

.
Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA Strength of SupportB CoverageA+ Formula Quality
Melatonin · 3 mg

Melatonin directly supports sleep timing and can help shorten sleep onset, especially when circadian timing is disrupted. Timed release is suited to sleep maintenance as well as circadian support.

A half-tablet serving is less convenient and can produce uneven dosing if the tablet does not split cleanly. Melatonin can cause next-day drowsiness, vivid dreams, or headache, so driving or other alertness-sensitive activity should wait until its effects are known.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Calcium
31 mg
Melatonin
3 mg
Adults 18–50 Women
Report overview
Melatonin · 3 mg OverallScore66
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA- Value

Timed release supports sleep maintenance, although the hard tablet may act more slowly at bedtime. The 3 mg amount fits the physiological range, but splitting a tablet makes dosing less straightforward. Serving cost is close to the collection median, while no independent purity certification is disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  3. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.
    Li T; Jiang S; Han M; Yang Z; Lv J; Deng C; Reiter RJ; Yang Y · Frontiers in neuroendocrinology · 2019
    Meta-analysis205 participants7 studies pooledSleep Support forMelatonin
  4. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  5. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  6. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  7. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin